HAND AND FLOWERS LIMITED

Company number 05618264 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: Hand and Flowers Limited

1. Financial Health Score: D+

Explanation: The patient is suffering from acute short-term financial anemia. While the underlying asset base (the "bone structure") remains substantial, the business is experiencing a severe liquidity crisis. Cash reserves have drained to dangerously low levels, and current liabilities vastly exceed current assets. The company is currently kept alive by a financial ventilator—in the form of intercompany loans from related businesses within the Tom Kerridge group. Without this external support, the patient would face immediate insolvency.


2. Key Vital Signs (As of 30 November 2024)

  • Pulse (Cash Position): £6,691
    • Interpretation: Dangerously weak. This is a dramatic drop from £23,114 in 2023 and a healthy £262,746 in 2022. The business has less than £7,000 in the bank to trade, representing a critical shortage of immediate financial oxygen.
  • Blood Pressure (Current Ratio): 0.14
    • Interpretation: Hypertensive crisis. Current assets (£606,873) cover only 14% of current liabilities (£4,371,394). A healthy ratio is typically between 1.5 and 2.0. The business owes £4.37 million within the next year but only has £0.6 million in short-term assets to pay it with.
  • Muscle Mass (Net Assets): £556,592
    • Interpretation: Atrophy. Net assets have halved from £1,143,663 in 2023. The business is burning through its equity reserves at an alarming rate.
  • Weight (Total Assets): £5,090,685
    • Interpretation: Stable but heavily leveraged. The asset base remains consistent with prior years, but it is heavily mortgaged by liabilities.
  • Heart Rate (Employee Count): 111
    • Interpretation: Elevated. Up from 102 in 2023, indicating increased payroll obligations that will put further strain on the weak cash position.

3. Symptoms Analysis

Symptom 1: The Debt Transfusion The most alarming symptom is the sudden shift in debt structure. In 2023, bank loans due after more than one year stood at £1.49 million. In 2024, that long-term debt has dropped to zero. Simultaneously, "Bank loans and overdrafts" due within one year have exploded from £323,489 to £1,526,946. This suggests the company has either breached a banking covenant, causing long-term debt to be called in early, or has had to shift its borrowing onto expensive short-term overdraft facilities just to survive the year.

Symptom 2: Reliance on the Corporate Family The balance sheet shows £1.92 million in "Other Creditors" due within one year (up from £1.3 million in 2023). The notes to the accounts reveal heavy related-party transactions: the company owes £518,158 to Tom Kerridge Media Limited (having borrowed £392,706 during the year). The business is relying heavily on the wider corporate group to act as a financial pacemaker, funding its day-to-day operations.

Symptom 3: Inventory and Trade Debtor Swelling While cash has plummeted, trade debtors have increased from £159,948 to £242,803, and stock has jumped from £14,464 to £36,313. This suggests the business is selling its services but struggling to collect the cash in time, keeping money tied up in the system rather than flowing through the company's veins.


4. Diagnosis

Diagnosis: Acute Liquidity Distress with Intercompany Dependency Hand and Flowers Limited is technically insolvent on a current-liabilities basis. It cannot pay its immediate debts from its own current assets. The business is surviving entirely on the life support of its short-term overdraft facility and intercompany loans from sister businesses. The Michelin-starred brand and freehold property (valued at £2.4m in the books) provide a strong underlying constitution, but the day-to-day working capital is severely hemorrhaging. The drop in net assets by over £587,000 in a single year shows that the business model is currently operating at a significant cash loss.


5. Prognosis & Recommendations

Prognosis: Guarded The future health of this specific legal entity depends entirely on the continued willingness of the Tom Kerridge group of companies to fund its operations. If the intercompany loans were to be called in, or the bank overdraft withdrawn, the company would face immediate administration.

Prescriptions for Financial Wellness:

  1. Debt Restructuring Surgery: The £1.52 million short-term bank debt must be refinanced into a long-term facility. Keeping this pressure on the current liabilities is unsustainable and restricts working capital flow.
  2. Intercompany Equity Transfusion:Rather than loading the company with more intercompany debt (which worsens the liquidity ratio), the parent/directors should consider a capital injection via equity. This will bolster the net assets and improve the balance sheet's structural integrity.
  3. Working Capital Physiotherapy:Implement strict debtor management. Trade debtors have jumped by over £80k. The business must chase outstanding payments aggressively to convert sales into vital cash flow. Similarly, review stock holdings—£36k is relatively small but has more than doubled; ensure this isn't tied up in wastage or slow-moving items.
  4. Cost Diet:With staff numbers rising to 111, management must ensure that labor costs are strictly aligned with revenue generation. In a low-cash environment, overheads must be meticulously controlled.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 28 August 2026